Journal of Cardiac Failure
Volume 12, Issue 8 , Pages 601-607 , October 2006

Cystatin C, Left Ventricular Hypertrophy, and Diastolic Dysfunction: Data From the Heart and Soul Study

  • Joachim H. Ix, MD

      Affiliations

    • From the Division of Nephrology, University of California San Francisco, San Francisco, California
    • Department of Medicine, University of California San Francisco, San Francisco, California
    • Corresponding Author InformationReprint requests: Joachim H. Ix, MD, Division of Nephrology, Department of Medicine, Box 0532, HSE 672, University of California, San Francisco, San Francisco, CA 94143–0532.
    • ,
  • Michael G. Shlipak, MD, MPH

      Affiliations

    • Department of Medicine, University of California San Francisco, San Francisco, California
    • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California
    • Section of General Internal Medicine, VA Medical Center, San Francisco, California
    • ,
  • Glenn M. Chertow, MD, MPH

      Affiliations

    • From the Division of Nephrology, University of California San Francisco, San Francisco, California
    • Department of Medicine, University of California San Francisco, San Francisco, California
    • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California
    • ,
  • Sadia Ali, MD, MPH

      Affiliations

    • Section of General Internal Medicine, VA Medical Center, San Francisco, California
    • ,
  • Nelson B. Schiller, MD

      Affiliations

    • Department of Medicine, University of California San Francisco, San Francisco, California
    • Division of Cardiology, University of California San Francisco, San Francisco, California
    • ,
  • Mary A. Whooley, MD

      Affiliations

    • Department of Medicine, University of California San Francisco, San Francisco, California
    • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California
    • Section of General Internal Medicine, VA Medical Center, San Francisco, California

Received 1 May 2006 ,Revised 18 July 2006 ,Accepted 25 July 2006.

References 

  1. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34
  2. Gokkusu CA, Ozden TA, Gul H, Yildiz A. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem. 2004;37:94–97
  3. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312–318
  4. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C—a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101:875–881
  5. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37:79–83
  6. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem. 1998;44:1535–1539
  7. Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005;16:1404–1412
  8. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function—a review. Clin Chem Lab Med. 1999;37:389–395
  9. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142:497–505
  10. Beattie MS, Shlipak MG, Liu H, Browner WS, Schiller NB, Whooley MA. C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study. Circulation. 2003;107:245–250
  11. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol. 2003;14:3233–3238
  12. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003;290:215–221
  13. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999;59:1–8
  14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
  15. Byrd BF, Wahr D, Wang YS, Bouchard A, Schiller NB. Left ventricular mass and volume/mass ratio determined by two-dimensional echocardiography in normal adults. J Am Coll Cardiol. 1985;6:1021–1025
  16. Nair D, Shlipak MG, Angeja B, Liu HH, Schiller NB, Whooley MA. Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study. Am J Cardiol. 2005;95:332–336
  17. Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography. J Am Soc Echocardiogr. 1996;9:119–128
  18. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation. 2003;107:659–663
  19. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation. 2003;108:2987–2992
  20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367
  21. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108:977–982
  22. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2001;37:1042–1048
  23. Mitsnefes M, Kimbal T, Kartal J, Kathman T, Mishra J, Devarajan P. Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney disease. Pediatr Nephrol. 2006;1293–1298
  24. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–1421
  25. Kassirer JP. Clinical evaluation of kidney function—glomerular function. N Engl J Med. 1971;285:385–389
  26. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282–2289
  27. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565–1574
  28. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med. 2004;55:373–394
  29. Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound. 2005;3:9
  30. Kitzman DW, Sheikh KH, Beere PA, Philips JL, Higginbotham MB. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol. 1991;18:1243–1250
  31. Shlipak MG, Katz R, Fried LF, Jenny NS, Stehman-Breen CO, Newman AB, et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol. 2005;45:268–271
  32. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060

 Supported by grants from the UCSF Academic Senate, the American Heart Association Fellow to Faculty Award (J.H.I.), and the Department of Veterans Affairs, the American Federation for Aging Research, the Robert Wood Johnson Foundation, the Ischemia Research and Education Foundation, and Dade Behring, Inc (M.A.W.). This study was supported by a research grant from Dade Behring, Inc. Dade Behring, Inc. played no role in the design, analysis, or preparation of the manuscript.Previously presented in abstract form at the American Heart Association 46th Annual Council on Epidemiology and Prevention, Phoenix, Arizona, March 3, 2006.All decisions regarding this manuscript were made by a guest editor.

PII: S1071-9164(06)00838-4

doi: 10.1016/j.cardfail.2006.07.005

Journal of Cardiac Failure
Volume 12, Issue 8 , Pages 601-607 , October 2006

Article Tools

* Image Usage & Resolution